Cancer Research The Future of Cancer Research: Science and Patient Impact  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 46, 81-88, January 1, 1986]
© 1986 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fresa, K. L.
Right arrow Articles by Murasko, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fresa, K. L.
Right arrow Articles by Murasko, D. M.

Role of Natural Killer Cells in the Mechanism of the Antitumor Effect of Interferon on Moloney Sarcoma Virus-transformed Cells1

Kerin L. Fresa2 and Donna M. Murasko3

Department of Microbiology and Immunology, The Medical College of Pennsylvania, Philadelphia, Pennsylvania 19129

The growth of tumors induced by inoculation of cells transformed by Moloney sarcoma virus can be inhibited by in situ administration of interferon (IFN) beginning one day after tumor challenge and continuing for 2 or 3 additional days. Inhibition of tumor growth by IFN was associated with a marked augmentation of natural killer (NK) cell activity, both in the spleen and at the site of tumor challenge, by day 5 after tumor challenge. However, using optimal conditions for IFN treatment, depletion of NK cells by in vivo treatment with anti-asialo GM1 prior to tumor challenge had no significant effect on inhibition of tumor growth by IFN. When the tumor load was greater or when IFN treatment was shorter, treatment with anti-asialo-GM1 partially abrogated the inhibition of tumor growth by IFN. In vitro assays gave no evidence of IFN enhancement of specific T-cell or activated macrophage antitumor effect. These results suggest that under optimal treatment conditions, the mechanism of the antitumor effect of IFN was independent of augmentation of NK activity, but under suboptimal conditions NK cells play a role in the mechanism of the antitumor effect of IFN.

1 This work was supported by grant AI-16840 from the NIH and grant IN-125-C from the American Cancer Society.

2 Recipient of a fellowship from the Samuel Roberts Noble Foundation. Present address: Department of Microbiology, The Pennsylvania State University College of Medicine, Hershey, PA 17033.

3 To whom requests for reprints should be addressed.

Received 3/28/85. Revised 7/26/85. Accepted 9/19/85.




This article has been cited by other articles:


Home page
Integr Cancer TherHome page
C. Guruvayoorappan and G. Kuttan
Effect of Amentoflavone on the Inhibition of Pulmonary Metastasis Induced by B16F-10 Melanoma Cells in C57BL/6 Mice
Integr Cancer Ther, June 1, 2007; 6(2): 185 - 197.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1986 by the American Association for Cancer Research.